Cigarette smoking induced elevated CXCL5 levels in BALF and plasma of patients with COPD Source: International Congress 2018 – COPD: novel pathological mechanisms in the airway epithelium Year: 2018
Potential association between cigarette smoking and IL-18 levels in induced sputum of healthy and asthma smokers Source: Eur Respir J 2007; 30: Suppl. 51, 363s Year: 2007
Leptin levels in induced sputum from patients with COPD are sensitive to smoking status Source: Eur Respir J 2005; 26: Suppl. 49, 660s Year: 2005
Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009
Increased levels of osteopontin in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Are there serum levels of MMP-2 and MMP-9 may be markers of COPD phenotypes? Source: Annual Congress 2012 - COPD treatment and varia Year: 2012
Cytokine expression in induced sputum in smokers with asthma or COPD and in healthy smokers Source: Eur Respir J 2003; 22: Suppl. 45, 392s Year: 2003
Serum levels of TIMP-1 and TIMP-2 are elevated in patients with pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003
Gender differences in 5- and 12/15-lipoxygenases products in bronchoalveolar lavage fluid from healthy never-smokers, smoker and COPD patients Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma Year: 2012
Induction-related changes in sputum neutrophils are associated with increased sputum levels of IL-8, but not sICAM Source: Eur Respir J 2002; 20: Suppl. 38, 189s Year: 2002
Increased levels of hyaluronan in induced sputum from COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003
Unaltered MMP-2/TIMP-2 and MMP-9/TIMP-1 ratios in the airways of occasional smokers after acute exposure to cigarette smoke Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007
Serum levels of TGFβ and VEGF in lung cancer patients and healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 43s Year: 2004
Genetic alterations in induced sputum of healthy smokers Source: Eur Respir J 2001; 18: Suppl. 33, 115s Year: 2001
The influence of steroidotherapy in COPD exacerbation on matrix metalloproteinase MMP-9 level in BAL, induced sputum and serum Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004
Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis Source: Eur Respir J 2015; 46: 1501-1503 Year: 2015
Serum periostin and eotaxin-2 as promising biomarkers in asthmatic smokers. Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Effect of smoking cessation on sputum HNP levels in COPD patients and asymptomatic smokers Source: Annual Congress 2008 - Towards smoking cessation Year: 2008
Increased levels of osteopontin in sputum supernatant in patients with COPD Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers Year: 2012
Elevated IL-8 levels in BAL fluid of individuals working in asbestos mine Source: Eur Respir J 2003; 22: Suppl. 45, 121s Year: 2003